Dietary energy substrates reverse early neuronal hyperactivity in a mouse model of Alzheimer's disease

作者: Misha Zilberter , Anton Ivanov , Sofya Ziyatdinova , Marat Mukhtarov , Anton Malkov

DOI: 10.1111/JNC.12127

关键词:

摘要: Deficient energy metabolism and network hyperactivity are the early symptoms of Alzheimer's disease (AD). In this study, we show that administration exogenous oxidative substrates (OES) corrects neuronal supply deficiency reduces amyloid-beta-induced abnormal activity in vitro epileptic phenotype AD model vivo. vitro, acute application protofibrillar amyloid-β1–42 (Aβ1–42) induced aberrant wild-type hippocampal slices was underlain by depolarization both resting membrane potential GABA-mediated current reversal potential. Aβ1–42 also impaired synaptic function long-term potentiation. These changes were paralleled clear indications metabolism, as indicated NAD(P)H signaling activity. However, when glucose supplemented with OES pyruvate 3-beta-hydroxybutyrate, failed to induce detrimental any above parameters. We administered same chronic supplementation a standard diet APPswe/PS1dE9 transgenic mice displaying AD-related epilepsy phenotype. ex-vivo slices, found subpopulations significantly depolarized potentials, mirroring abnormalities observed under Aβ1-42 application. Ex-vivo cortex fed displayed signs such strongly reduced tolerance hypoglycemia. Transgenic possessed brain glycogen levels twofold lower than those mice. none metabolic dysfunctions OES-enriched diet. vivo, dietary abated hyperexcitability, frequency epileptiform discharges spikes decreased placed on Altogether, our results suggest malfunctions underlying hyperexcitability can be prevented native substrates.

参考文章(93)
Uday Saxena, Bioenergetics breakdown in Alzheimer's disease: targets for new therapies. International journal of physiology, pathophysiology and pharmacology. ,vol. 3, pp. 133- 139 ,(2011)
Magdalena E. Cuevas, Henny Haensgen, Fernando J. Sepúlveda, Gabriela Zegers, Jorge Roa, Carlos Opazo, Luis G. Aguayo, Soluble Aβ(1-40) peptide increases excitatory neurotransmission and induces epileptiform activity in hippocampal neurons. Journal of Alzheimer's Disease. ,vol. 23, pp. 673- 687 ,(2011) , 10.3233/JAD-2011-091717
Sylvain Rheims, Carl D. Holmgren, Genevieve Chazal, Jan Mulder, Tibor Harkany, Tanya Zilberter, Yuri Zilberter, GABA action in immature neocortical neurons directly depends on the availability of ketone bodies Journal of Neurochemistry. ,vol. 110, pp. 1330- 1338 ,(2009) , 10.1111/J.1471-4159.2009.06230.X
C. S. Casley, L. Canevari, J. M. Land, J. B. Clark, M. A. Sharpe, β-Amyloid inhibits integrated mitochondrial respiration and key enzyme activities Journal of Neurochemistry. ,vol. 80, pp. 91- 100 ,(2001) , 10.1046/J.0022-3042.2001.00681.X
Renu Sah, Rochelle D. Schwartz-Bloom, Optical Imaging Reveals Elevated Intracellular Chloride in Hippocampal Pyramidal Neurons after Oxidative Stress The Journal of Neuroscience. ,vol. 19, pp. 9209- 9217 ,(1999) , 10.1523/JNEUROSCI.19-21-09209.1999
P. Vernia, G. Monteleone, G. Grandinetti, G. Villotti, E. Di Giulio, G. Frieri, A. Marcheggiano, F. Pallone, R. Caprilli, A. Torsoli, Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis. Digestive Diseases and Sciences. ,vol. 45, pp. 976- 981 ,(2000) , 10.1023/A:1005537411244
Alexander Kurz, Robert Perneczky, Amyloid clearance as a treatment target against Alzheimer's disease. Journal of Alzheimer's Disease. ,vol. 24, pp. 61- 73 ,(2011) , 10.3233/JAD-2011-102139
John Hardy, The amyloid hypothesis for Alzheimer’s disease: a critical reappraisal Journal of Neurochemistry. ,vol. 110, pp. 1129- 1134 ,(2009) , 10.1111/J.1471-4159.2009.06181.X
Robert J. Mark, Zhen Pang, James W. Geddes, Koji Uchida, Mark P. Mattson, Amyloid β-Peptide Impairs Glucose Transport in Hippocampal and Cortical Neurons: Involvement of Membrane Lipid Peroxidation The Journal of Neuroscience. ,vol. 17, pp. 1046- 1054 ,(1997) , 10.1523/JNEUROSCI.17-03-01046.1997